Anti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.

Berkowitz MJ, Arzoo KK

Open source

DOI
10.7759/cureus.117545
Published
2026 Oct
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.117545,
  title = {Anti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.},
  author = {Berkowitz MJ and Arzoo KK},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.117545},
  url = {https://doi.org/10.7759/cureus.117545}
}

RIS

TY  - JOUR
TI  - Anti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.
AU  - Berkowitz MJ
AU  - Arzoo KK
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.117545
UR  - https://doi.org/10.7759/cureus.117545
ER  - 

APA

MJ, B., & KK, A. (2026). Anti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.. Cureus. https://doi.org/10.7759/cureus.117545

Source records